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Introduction {#jdi12122-sec-0005}
============

Bleeding on probing (BOP) is highly prevalent, and is a major component of routine periodontal examinations carried out in clinical settings and dental clinical research. However, its clinical relevance in the disease progression from chronic gingivitis to severe periodontal disease remains unclear. BOP is a classic sign of periodontal inflammation, and has been observed to be highly correlated to active periodontal disease. Thus, it could serve as an indicator of disease activity[1](#jdi12122-bib-0001){ref-type="ref"}. In contrast, although there is a strong correlation between BOP and gingival inflammation[2](#jdi12122-bib-0002 jdi12122-bib-0003){ref-type="ref"}, BOP might have limited predictability in terms of periodontal disease progression[4](#jdi12122-bib-0004 jdi12122-bib-0005){ref-type="ref"}. Nevertheless, if this measurement is carried out properly, BOP could be an additional useful clinical tool to detect the presence and monitor the development of acute or chronic inflammatory processes, regardless of the stage of the disease progression. In individuals with extensive periodontal disease, this parameter could be highly pertinent to their chronic inflammatory status and could, therefore, serve as an additional screening or monitoring tool for disease progression.

Studies have suggested that diabetes is a systemic disease well documented as a risk factor for the development of periodontal disease[6](#jdi12122-bib-0006){ref-type="ref"}. As such, diabetes is an ideal model to study the natural history of this oral disease and its progression. Still, the mechanisms underlying the transition from chronic gingivitis to periodontal disease among people with diabetes are not known. Nor is it clear whether the transition rate is higher among those with type 2 diabetes or those presenting with prediabetic conditions compared with individuals in the general population showing no evidence of systemic disease. Therefore, comparing BOP, in addition to probing depth (PD) and clinical attachment loss (CAL), between individuals with or without prediabetic conditions is important. The findings of such a study could suggest means for prevention and control of both periodontal disease and diabetes among high‐risk populations. Indeed, the association between chronic gingival and/or periodontal inflammation and prediabetic conditions is poorly understood and has rarely been studied.

The present study aimed to evaluate the potential association between prediabetes (presence of impaired fasting glucose \[IFG\] and/or 2‐h impaired glucose tolerance \[IGT\]), and the occurrence of gingival and/or periodontal inflammation among Hispanics consisting of Puerto Rican adults residing in the San Juan, Metropolitan area.

Materials and Methods {#jdi12122-sec-0006}
=====================

Study Population {#jdi12122-sec-0007}
----------------

A cross‐sectional study including 100 Puerto Rican overweight or obese adults aged 40--65 years and residing in the San Juan, Puerto Rico, metropolitan area was carried out in November 2008[7](#jdi12122-bib-0007){ref-type="ref"}. Participants were excluded if they had diagnosis of diabetes (type 1 or 2, or others) and metastatic cancer, or had less than four natural teeth (to allow periodontal examination). Other exclusion criteria included: (i) taking either insulin or oral antidiabetic agents; (ii) having braces or orthodontic appliances that might make the periodontal measurements difficult; (iii) being pregnant; (iv) diagnosis of hypoglycemia; (v) history of coronary heart disease, congenital heart murmurs, heart valve disease, congenital heart disease, endocarditis, stroke, rheumatic fever and hemophilia or bleeding disorders; (vi) undergoing current dialysis treatment; (vii) undergoing current anticoagulation therapy; or (viii) requiring antibiotic prophylaxis before a dental procedure.

A total of 141 Puerto Rican adults originally responded to the recruitment. Of these, 27 were not eligible, two refused to participate in the study, 11 participants did not appear for their appointments, and one participant, who had a medical problem during the study procedure, dropped out. Among the remaining 100 participants who successfully completed all the study procedures, five participants who had fasting plasma glucose (FPG ≥126 mg/dL) and/or oral glucose tolerance test (2‐h postprandial glucose ≥200 mg/dL) indicative of diabetes, and one participant who was later found to be ineligible (older than 65 years) were excluded from the analysis. Therefore, the final sample for statistical analysis included 94 overweight or obese Puerto Rican adult participants. The pilot study was approved by the institutional review board at the University of Puerto Rico, and all participants provided signed informed consent before any study procedures.

Measurements of Glucose, Insulin, Homeostasis Model Assessment and Other Serum Lipid Levels {#jdi12122-sec-0008}
-------------------------------------------------------------------------------------------

Participants were asked to fast for 10 h before their appointments, and up to the last blood drawing on that appointment. After signing the informed consent, FPG was collected. The 1 and 2‐h postprandial blood samples were subsequently gathered after glucose beverage consumption (296 mL of glucola containing 75 g of dextrose). Participants\' fasting glucose level is determined to be impaired if it is between 100--125 mg/dL, the 1‐h glucose tolerance level is impaired if it is ≥155 mg/dL (1‐h IGT) and the 2‐h glucose tolerance is impaired if the level is between 140 and 199 mg/dL (2‐h IGT). The cut‐off point of 155 mg/dL for the 1‐h oral glucose tolerance test is associated with obesity[7](#jdi12122-bib-0007){ref-type="ref"}, and can be used to identify individuals who are at risk for type 2 diabetes and vascular atherosclerosis[8](#jdi12122-bib-0008 jdi12122-bib-0009 jdi12122-bib-0010){ref-type="ref"}. More detailed information on the assessment of glucose, fasting insulin, homeostasis model assessment (HOMA) and serum lipid levels, such as triglyceride and high‐density lipoprotein (HDL) cholesterol is described in our previous article[7](#jdi12122-bib-0007){ref-type="ref"}. The prediabetic condition is defined as having either IFG or 2‐h IGT.

Periodontal Examination {#jdi12122-sec-0009}
-----------------------

Periodontal examination, carried out by one of three trained and calibrated dental examiners, included measures of probing depth, gingival recession, CAL and BOP. PD is the depth of the periodontal pocket measured as the distance in millimeters between the free gingival margin (FGM) and the base of the pocket. Gingival recession is the distance in millimeters between the FGM and the line of the cemento‐enamel junction (CEJ). CAL is clinically presented by the total denudation of the root surface of the tooth, and computed as the difference in millimeters between the measure of PD and the gingival recession (CEJ to FGM distance). BOP, which indicates the presence or absence of bleeding at any of six sites per tooth during periodontal probing procedures, was recorded as follows: the probe was gently inserted to the base of the sulcus or pocket with a probing force of no more than 20 g, and BOP was considered positive when the probed site bled within 20s after removal of the probe tip[3](#jdi12122-bib-0003){ref-type="ref"}. The severity of the BOP was determined by the percentage of the number of teeth with any site bleeding during the periodontal probing.

Other Data Collection {#jdi12122-sec-0010}
---------------------

Participants had three consecutive blood pressure measurements. Anthropometric measures, such as weight, height, and waist and hip circumferences, were collected during the interview, and the body mass index (BMI) and waist‐to‐hip ratio were computed. Briefly, an in‐person interview gathered information on demographic and socioeconomic variables, such as age, sex, marital status and total years of education. Health‐related lifestyle habits included smoking status (ever smoked vs never smoked) and history of alcohol consumption (current vs never or former).

Statistical Analysis {#jdi12122-sec-0011}
--------------------

We categorized the participants as high or low BOP (percentage of teeth with BOP greater than or equal to the median and percentage of teeth with BOP less than the median). The two groups were compared using the mean or median and standard deviation for continuous variables, and the frequency and percentage for categorical variables. In our analyses, we computed the odds ratios (OR) and 95% confidence intervals (CI) of the association between both impaired fasting glucose, and prediabetes and BOP. The estimates were adjusted for potential confounding factors based on the literature[11](#jdi12122-bib-0011 jdi12122-bib-0012){ref-type="ref"}. The association between BOP and fasting glucose was assessed using linear regression, and the adjusted mean percentages of BOP (least‐squares means) observed among participants with impaired glucose levels or the prediabetic condition were compared with those of participants with a normal range of glucose levels or no prediabetic condition using generalized linear models. The association between IFG or prediabetes and percentage of bleeding on probing (P1) within specific characteristics of the population was also assessed using linear regression.

Results {#jdi12122-sec-0012}
=======

The general characteristics of the study population by BOP are shown in Table [1](#jdi12122-tbl-0001){ref-type="table-wrap"}. The mean age of participants with a percentage of BOP greater than or equal to the median (*n* = 51) was 50 years (standard deviation \[SD\] 7.5) and 52 years (SD 6.9) among participants with a percentage of BOP less than the median (*n* = 43). Approximately 35% of the participants with high BOP were male, compared with 26% among participants with low BOP. Among participants with high BOP, approximately 63% were never smokers, 20% former smokers and 18% current smokers; the corresponding numbers were similar among participants with low BOP (63%; 21 and 16%, respectively).

###### General characteristics of the study population by bleeding on probing

  Characteristics                                            \% BOP \<median (*n* = 43)   \% BOP ≥median (*n* = 51)
  ---------------------------------------------------------- ---------------------------- --------------------------------------------------
  Age (years)                                                52.2 ± 6.9                   50.0 ± 7.5
  Male                                                       11 (25.6)                    18 (35.3)
  Years of education                                         6.4 ± 2.4                    6.5 ± 2.2
  Never smoked                                               27 (62.8)                    32 (62.8)
  Former smokers                                             9 (20.9)                     10 (19.6)
  Current smokers                                            7 (16.3)                     9 (17.7)
  Current alcohol consumption                                13 (30.2)                    27 (52.9)[a](#jdi12122-note-0001){ref-type="fn"}
  Body mass index (height/weight^2^)                         32.2 ± 5.1                   34.0 ± 6.9
  Hypertension                                               26 (60.5)                    32 (62.8)
  Waist circumference (≥88 cm for men,≥102 cm for women)     37 (86.1)                    41 (82.0)
  Glucose abnormalities (continuous)                                                      
  Fasting glucose (mg/dL)                                    89.5 ± 7.5                   91.3 ± 9.4
  1‐h OGTT (mg/dL)                                           128.6 ± 34.6                 143.9 ± 43.6
  2‐h OGTT (mg/dL)                                           103.9 ± 24.5                 108.9 ± 27.3
  Fasting insulin (μIU/mL)                                   14.0 ± 7.1                   16.1 ± 9.3
  Glucose abnormalities (categories)                                                      
  Impaired fasting glucose: IFG (100--125 mg/dL)             3 (7.0)                      10 (19.6)
  1‐h Impaired glucose tolerance: 1‐h IGT (≥155 mg/dL)       8 (18.6)                     21 (41.2)[a](#jdi12122-note-0001){ref-type="fn"}
  2‐h Impaired glucose tolerance: 2‐h IGT (140--199 mg/dL)   3 (7.0)                      4 (7.8)
  Prediabetic condition (IFG or 2‐h IGT)                     5 (11.6)                     12 (23.5)

\**P*‐value ≤ 0.05. BOP, bleeding on probing; IFG, impaired fasting glucose; IGT, impaired glucose tolerance; OGTT, oral glucose tolerance test; SD, standard deviation.
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Participants with high BOP were significantly more likely to be current alcohol drinkers (53% vs 30%) than those with low BOP. In addition, the groups with high and low BOP were similar with respect to hypertension (63% vs 61%), body mass index (mean 34, SD 6.9 vs mean 32, SD 5.1) and high waist circumference (82% vs 86%).

Participants with high BOP had insignificantly higher mean levels of fasting glucose (91.3 mg/dL, SD 9.4 vs 89.5 mg/dL SD 7.5), insulin (16.1 μIU/mL, SD 9.3 vs 14.0 μIU/mL, SD 7.1) and 1‐h oral glucose tolerance test (143.9 mg/dL, SD 43.6 vs 128.6 mg/dL, SD 34.6) than participants with low BOP. Participants with high BOP were more likely to have IFG (19.6% vs 7%), 1‐h IGT (41.2% vs 18.6%), 2‐h IGT (7.8% vs 7%) and prediabetic condition (23.5% vs 11.6%) as compared with those with low BOP; however, only the 1‐h IGT was significant.

All participants had at least one tooth site with CAL ≥3 mm (data not shown). Compared with participants with low BOP, those with high BOP had insignificantly fewer tooth sites with CAL of at least 4 mm or CAL of at least of 5 mm. However, participants with high BOP also tended to have insignificantly more tooth sites with deep PD of at least 5 mm than those with low BOP (data not shown).

Table [2](#jdi12122-tbl-0002){ref-type="table-wrap"}a shows the results of the logistic regression models for the association between glucose metabolic components and BOP. No significant association between fasting glucose level and higher prevalence of BOP was observed; the age‐adjusted OR was 1.4 (95% CI 0.8--2.3) for a 10‐mg/dL increment. The estimate remained non‐significant after adjustment for age, sex, smoking status, alcohol consumption, waist circumference (in category) and number of missing teeth (OR 1.5, 95% CI 0.9--2.6). Also, no significant association between 2‐h glucose tolerance level and BOP was observed. In contrast, the association was significant and similar in both crude and full adjustment of estimates for the association between 10‐mg/dL increment of 1‐h glucose level and BOP (OR 1.1, 95% CI 1.0--1.3). The crude OR of the association between impaired fasting glucose and high BOP was 4.0 (95% CI 1.0--16.4). Multivariate analyses increased the OR to 5.5 (95% CI 1.2--25.3). The association between 1‐h impaired glucose tolerance and a high prevalence of BOP was also significant (adjusted OR 3.7, (95% CI 1.3--10.6). The associations between 2‐h impaired glucose tolerance, fasting insulin or HOMA and high percentage of BOP were not statistically significant. Prediabetes was associated with increased BOP, with an adjusted OR of 3.6 (95% CI 1.0--13.2).

###### Estimates of the association between prediabetic conditions and bleeding on probing

  \(a\) Using logistic regression models (Outcome: BOP \< median vs BOP ≥ median)                      
  --------------------------------------------------------------------------------- ------------------ ----------------------------------------------------------
  Fasting glucose (10 mg/dL)[‡](#jdi12122-note-0002){ref-type="fn"}                 1.4 (0.8 --2.3)    1.5 (0.9 --2.6)
  1‐h Glucose (10 mg/dL)[§](#jdi12122-note-0002){ref-type="fn"}                     1.1 (1.0 --1.3)    1.1 (1.0 --1.3)[\*](#jdi12122-note-0002){ref-type="fn"}
  2‐h Glucose (10 mg/dL)[¶](#jdi12122-note-0002){ref-type="fn"}                     1.1 (0.9 --1.3)    1.2 (0.8 --1.4)
  IFG (yes/no)                                                                      4.0 (1.0 --16.4)   5.5 (1.2 --25.3)[\*](#jdi12122-note-0002){ref-type="fn"}
  IGT (1‐h)                                                                         3.3 (1.3 --8.8)    3.7 (1.3 --10.6)[\*](#jdi12122-note-0002){ref-type="fn"}
  IGT (2‐h)                                                                         1.2 (0.2 --5.7)    1.3 (0.2 --7.3)
  Fasting insulin                                                                   1.0 (1.0 -- 1.2)   1.0 (1.0 --1.1)
  HOMA                                                                              1.1 (0.9 --1.4)    1.2 (0.9 --1.5)
  Prediabetes (yes/no)                                                              2.1 (0.8 -- 8.3)   3.6 (1.0 --13.2)[\*](#jdi12122-note-0002){ref-type="fn"}

  \(b\) Using [ancova]{.smallcaps} (multiple linear regression or generalized linear model) (Outcome: Percentage of bleeding: continuous form)                
  ---------------------------------------------------------------------------------------------------------------------------------------------- ------------ ----------------------------------------------------
  Normal (No IFG)                                                                                                                                27.0 ± 2.4   26.8 ± 2.3[\*](#jdi12122-note-0002){ref-type="fn"}
  IFG                                                                                                                                            43.2 ± 5.9   43.8 ± 6.0
  Normal GT (1‐h)                                                                                                                                27.2 ± 2.7   27.0 ± 2.7
  IGT (1‐h)                                                                                                                                      33.9 ± 4.0   34.1 ± 4.1
  Normal GT (2‐h)                                                                                                                                29.4 ± 2.3   29.1 ± 2.3
  IGT (2‐h)                                                                                                                                      26.8 ± 8.3   29.8 ± 8.3
  Normal insulin: (\<14)                                                                                                                         29.5 ± 3.3   28.2 ± 3.5
  High insulin: (≥14)                                                                                                                            29.0 ± 3.1   30.1 ± 3.3
  Normal HOMA (\<3)                                                                                                                              30.9 ± 3.3   30.1 ± 3.4
  High HOMA (≥3)                                                                                                                                 27.8 ± 3.1   28.4 ± 3.2
  Normal (no IFG, no IGT 2‐h)                                                                                                                    27.4 ± 2.5   27.0 ± 2.4[\*](#jdi12122-note-0002){ref-type="fn"}
  Prediabetics                                                                                                                                   37.7 ± 5.2   39.0 ± 5.3

\**P*‐value ≤ 0.05. †Adjusted for age, sex, smoking status (never, former, current), alcohol consumption (current vs never or former), waist circumference (in category), and number of missing teeth. ‡Fasting glucose. §1‐h glucose. ¶2‐h glucose in 10 mg/dL increments. [ancova]{.smallcaps}, analysis of covariance; BOP, bleeding on probing; CI, confidence interval; GT, glucose tolerance; HOMA, homeostasis model assessment; IFG, impaired fasting glucose; IGT, impaired glucose tolerance; OR, odds ratio; SE, standard error.
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When analysis of covariance was used to assess the association between plasma glucose levels, presence of IFG or prediabetic conditions and the increase in percentage of teeth with BOP (continuous form), results were generally similar to those of the logistical regression models (Table [2](#jdi12122-tbl-0002){ref-type="table-wrap"}b). The age‐adjusted least squares mean of percentage of BOP among participants with normal fasting glucose was lower compared with that of participants with impaired fasting glucose (normal FG: least squares mean 27.0 vs IFG 43.2). The association was significant after full adjustment of the estimate (normal FG: least squares mean 26.8 vs IFG 43.8). A similar pattern occurred for the association between 1 and 2‐h IGT, high insulin level, and percentage of BOP, but the associations were not significant. The percentage of BOP (least squares mean adjusted for age, sex, smoking status, alcohol consumption, waist circumference and number of missing teeth) was 27.0 for 1‐h normal GT vs 34.1 for 1‐h IGT; 29.1 for 2‐h normal GT vs 29.8 for 2‐h IGT and 28.2 for normal insulin (\<14: median) vs 30.1 for high insulin. The percentage of BOP was 30.1 for normal HOMA (\<3: median) vs 28.4 for high HOMA[13](#jdi12122-bib-0013){ref-type="ref"}. The association between prediabetes (IFG or 2‐h IGT) and percentage of BOP was significant (normal: mean percentage of BOP 27.0 vs prediabetic 39.0).

The association between IFG level and percentage of BOP (continuous form) within population subgroups, such as age, smoking, periodontal status, alcohol consumption and obesity, were assessed (data not shown). The association was strong among older participants, participants who had ever smoked, participants with severe PD, obesity, low triglycerides or high HDL cholesterol.

We also assessed the association between the prediabetic condition and the percentage of BOP by certain characteristics (Table [3](#jdi12122-tbl-0003){ref-type="table-wrap"}). The association between the prediabetic condition and BOP was stronger and significant among older participants (β = 17.7, *P* = 0.03), participants who ever smoked (β = 25.9, *P* = 0.02), participants with severe PD (≥5 mm; β = 21.2, *P *= 0.03), low triglycerides (150 mg/dL; β = 19.1, *P* = 0.03), and high HDL cholesterol (≥40 mg/dL; β = 16.8, *P *= 0.04).

###### Association between prediabetic conditions and percentage of bleeding on probing by certain characteristics (age, smoking, periodontal status, alcohol consumption, obesity)

  Characteristics       *n*   β (SE)[†](#jdi12122-note-0003){ref-type="fn"}   *P*‐value
  --------------------- ----- ----------------------------------------------- ----------------------------------------------
  Age                                                                         
  \<51 years            43    −3.9 (9.1)                                      0.67
  ≥51 years             50    17.7 (7.6)                                      0.03[\*](#jdi12122-note-0003){ref-type="fn"}
  Smoking status                                                              
  Never smoked          58    −0.6 (6.6)                                      0.93
  Ever smoked           35    25.9 (10.4)                                     0.02[\*](#jdi12122-note-0003){ref-type="fn"}
  Periodontal status                                                          
  PD \<5 mm             50    0.07 (7.6)                                      0.99
  PD ≥5 mm              43    21.2 (9.5)                                      0.03[\*](#jdi12122-note-0003){ref-type="fn"}
  Alcohol consumption                                                         
  Never or former       53    7.6 (7.1)                                       0.29
  Current               40    16.6 (11.5)                                     0.16
  Obesity                                                                     
  Overweight            34    18.4 (16.3)                                     0.27
  Obese                 59    10.3 (6.3)                                      0.11
  Triglycerides                                                               
  \<150 mg/dL           62    19.1 (8.4)                                      0.03[\*](#jdi12122-note-0003){ref-type="fn"}
  ≥150 mg/dL            31    1.5 (8.7)                                       0.86
  HDL cholesterol                                                             
  ≥40 mg/dL (0)         53    16.8 (8.1)                                      0.04[\*](#jdi12122-note-0003){ref-type="fn"}
  \<40 mg/dL (1)        40    5.6 (10.4)                                      0.59

\**P*‐value ≤ 0.05. The total number of participants in this analysis was reduced to *n* = 93, as one participant did not have information on waist circumference. †Adjusted for age, sex, smoking status (never vs ever), alcohol consumption (never or former vs current), waist circumference (category) and number of missing teeth, correspondingly. HDL, high‐density; PD, probing depth; SE, standard error.

John Wiley & Sons, Ltd

Discussion {#jdi12122-sec-0013}
==========

Findings from the present study suggested a potential association between impaired fasting plasma glucose level and prediabetes, and gingival and/or periodontal bleeding on gentle probing of the periodontal tissues. Higher BOP was observed among overweight or obese adult Puerto Ricans with impaired fasting glucose or prediabetes. Only a few studies have assessed the possible link between early‐stage diabetes and BOP indicating current gingival/periodontal inflammation. A study by Noack *et al*[14](#jdi12122-bib-0014){ref-type="ref"}. did not find a significant difference in the percentage of sites showing BOP between individuals with IGT and individuals with normal glucose levels. However, that study did not assess the link between BOP and prediabetes. Similarly, a non‐significant greater percentage of sites with gingival bleeding was observed across type 2 diabetic patients and patients with impaired glucose tolerance as compared with a normal population[15](#jdi12122-bib-0015){ref-type="ref"}. Nevertheless, it was not clear whether the gingival bleeding indicated in the other study used BOP or gingival index[16](#jdi12122-bib-0016){ref-type="ref"}. A recent study by Javed *et al*.[17](#jdi12122-bib-0017){ref-type="ref"} found higher severe self‐perceived gingival bleeding and clinical signs of periodontal inflammation, such as bleeding on probing, in patients with prediabetes as compared with non‐prediabetic controls.

Prediabetes has been associated with periodontal disease measures, such as alveolar bone loss[18](#jdi12122-bib-0018 jdi12122-bib-0019){ref-type="ref"}. A higher percentage of BOP was found among individuals with type 2 diabetes as compared with non‐diabetic individuals[20](#jdi12122-bib-0020 jdi12122-bib-0021 jdi12122-bib-0022){ref-type="ref"}. Other recent studies have reported positive or non‐significant associations mostly between BOP and established type 2 diabetes[23](#jdi12122-bib-0023 jdi12122-bib-0024 jdi12122-bib-0025 jdi12122-bib-0026){ref-type="ref"}.

Multiple studies have postulated different mechanism pathways explaining the potential association between established diabetes and periodontal diseases[27](#jdi12122-bib-0027 jdi12122-bib-0028 jdi12122-bib-0029 jdi12122-bib-0030 jdi12122-bib-0031 jdi12122-bib-0032){ref-type="ref"}. Patients with diabetic mellitus have a higher risk for periodontitis development, probably because of vascular changes, neutrophil dysfunction, altered systemic inflammatory responses[33](#jdi12122-bib-0033){ref-type="ref"}, altered collagen synthesis, microbiotic factors or genetic predisposition[34](#jdi12122-bib-0034 jdi12122-bib-0035){ref-type="ref"}.

In contrast, the potential biological mechanisms explaining the association between moderate glycemic intolerance and periodontal status have been scarcely studied. It is important to assess early stages to better understand the natural history and interrelationships between the two diseases. Previous studies have assessed the potential role of reactive oxygen species in the association. Impaired glycemic status is associated with an increased production and accumulation of reactive oxygen species in the body tissues including the periodontium[36](#jdi12122-bib-0036 jdi12122-bib-0037){ref-type="ref"}.

The present study evaluated and controlled for biologically meaningful potential confounders, such as age, sex, smoking status, alcohol consumption, waist circumference and number of missing teeth, for the estimates of the association between pre‐diabetic conditions and BOP. We also assessed obesity, as expressed by waist circumference (categorical form was used as it was a stronger confounder) and BMI as confounders. We assessed the amount of smoking as a potential residual confounding factor in the model, but it did not contribute to a significant change in the estimates. For example, the adjusted OR with FPG was 5.5 (95% CI 1.2--25.3) without adjusting for the variable 'amount of smoking' vs OR: 5.9 (95% CI 1.2--28.2) adjusting for 'amount of smoking'.

When the association between prediabetes and the percentage of BOP was assessed by the level of the characteristics of the study population (shown in Table [3](#jdi12122-tbl-0003){ref-type="table-wrap"}), there were significant associations among older individuals and those who had ever smoked or had deep pocket depth, low triglycerides and high HDL cholesterol. No significant associations were observed among the remaining specific characteristics, such as alcohol consumption and obesity. Whether the significant observed association between IFG or prediabetes and a higher percentage of BOP among participants with low triglycerides or high HDL cholesterol was real or by chance still remains to be further investigated in an adequately large and prospective study.

We did not find any association between the continuous form of fasting glucose level and the presence of BOP. Other than the possible interpretations resulting from the limitations of the present study, our findings might indicate threshold effects only with high glucose levels, parallel to the findings commonly observed among individuals with established diabetes[20](#jdi12122-bib-0020 jdi12122-bib-0021 jdi12122-bib-0022){ref-type="ref"}.

Although BOP measures are routinely carried out at dental clinical examination, BOP has not been given much attention. Gingival bleeding after stimulation of the gingival sulcus or pocket has been found to be associated with periodontal inflammation in clinical[3](#jdi12122-bib-0003 jdi12122-bib-0038 jdi12122-bib-0039 jdi12122-bib-0040){ref-type="ref"}, histopathological[2](#jdi12122-bib-0002 jdi12122-bib-0041){ref-type="ref"} and bacteriological[3](#jdi12122-bib-0003 jdi12122-bib-0042){ref-type="ref"} aspects of the disease. Regarding the inherent ability of BOP to distinguish the disease condition, previous studies have reported a low sensitivity, but high specificity, of this measurement[43](#jdi12122-bib-0043){ref-type="ref"}. These findings could depend on the prevalence of the disease to be measured in the study population. BOP is frequently encountered in individuals at high risk of developing chronic systemic inflammatory diseases[20](#jdi12122-bib-0020 jdi12122-bib-0021 jdi12122-bib-0022){ref-type="ref"}. As previously stated, the present findings suggested that BOP is more frequently found in participants with impaired fasting glucose or prediabetes among those with the presence of deep pocket depths (PD ≥5 mm) than without.

The sample size and cross‐sectional design of the present study limited the interpretation of the present findings. We did not collect data related to oral hygiene status, such as Plaque Index[44](#jdi12122-bib-0044){ref-type="ref"} and Gingival Index[16](#jdi12122-bib-0016){ref-type="ref"}. Thus, the potential confounding effect of supra‐gingival plaque with the presence of bleeding of the marginal gingiva[44](#jdi12122-bib-0044 jdi12122-bib-0045){ref-type="ref"} might have masked the BOP measurement as well.

In contrast, as previously mentioned, the present study has some strength in that it assessed the potential connection between early‐stage diabetes and oral health status. Specifically, the association between impaired fasting glucose and prediabetes and BOP, as a parameter of gingival/periodontal disease, was observed. More studies need to be carried out, because this measurement, in conjunction with other periodontal parameters, such as PD and CAL, could give a more complete picture of an individual\'s current inflammatory status. In the present study, the significance of the association between impaired fasting glucose and periodontal disease, defined by the presence of deep pocket depth and a high prevalence of BOP, is borderline (*P* = 0.08). Thus, if our preliminary association between prediabetes and gingival/periodontal inflammation are supported by large prospective studies, this could ultimately yield substantial benefits, as the use of these measurements in additional screening or monitoring would provide a tool for the early prevention or control of chronic inflammatory development of periodontal disease, and for predicting diabetes development among high‐risk populations.
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